February 28, 2013
5 PM in Mainz, Germany
TRON – Building 708 at University Medical Center Mainz
Prof. Ferdinando Nicoletti
Medical Laboratory Sciences at the University of Catania, Italy
“ Macrophage migration inhibitory factor as novel therapeutic target for the treatment of type 1 diabetes and other autoimmune diseases”
Professor Ferdinando Nicoletti, MD, is a full Professor of Medical Laboratory Sciences at the University of Catania, Italy. Prof. Nicoletti is a recognized expert in the discovery and development of new drugs for the treatment of autoimmune diseases and cancer. He serves and has served as an advisor to and collaborator with leading pharmaceutical companies including Amgen, MerckSerono, Leo Pharma, Merck and Pfizer, that led to the clinical development of anti-cancer and immunomodulatory drugs. Prof. Nicoletti has published more than 200 papers in peer reviewed scientific journals, is inventor on 5 patents, and he is in the editorial board of several international journals.